A local medtech startup behind an AI sepsis diagnostic tool recognized by Time magazine has landed $40 million in funding.

Most Snap-on products may be expensive, but some of the brand's high quality tools deliver durability and functionality at ...

After a cardiac arrest, families and doctors are often faced with agonizing uncertainty about a patient's chances of recovery ...

Most Snap-on tools are pricey, but one "intelligent" device sits at the very top of the price list. See the tech that ...

As AI promises early detection, preventive care and efficiency gains, experts warn that weak regulation, data gaps and misuse ...

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

Five diagnostic tools are critical to assist surgeons in choosing the most appropriate IOL for the patient and maintaining ...

Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life ...

WASHINGTON, CT, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Evexia Diagnostics, a leading provider of ...

Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic ...

Astronics Corporation (NASDAQ:ATRO) is included in our list of the 11 Best Performing Stocks in the Last 12 Months. On January 21, 2026, Astronics Corporation (NASDAQ:ATRO) launched its latest ...

The tablet-based TabCAT tool demonstrates strong convergent validity with traditional tests for early-onset Alzheimer disease (EOAD).